Polysaccharide with wound healing effect as well as preparation method and application thereof
The homogeneous polysaccharide BSPS obtained by separation and purification from white and fresh tubers through modern column chromatography technology solves the problem of incomplete preservation of active ingredients and crude polysaccharides in the prior art, realizes efficient extraction and structural characterization, significantly promotes wound healing, and provides An effective pharmaceutical composition for trauma treatment is used.
Patent Information
- Application Number
- CN202411021873.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-29
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-07-29
AI Technical Summary
The existing white and polysaccharides are extracted from dried tubers. The active ingredients are incompletely preserved and used to evaluate wound healing are crude polysaccharides, and there is a lack of efficient extraction and purification technology for fresh tubers.
The homogeneous polysaccharide - Baihe polysaccharide BSPS was obtained by using modern column chromatography technology, and its structure was characterized by a variety of spectral and spectral techniques combined with chemical analysis methods. The preparation method includes water extraction and ethanol Precipitation, deprotein, dialysis and freeze-dried, separated using DEAE-Sephadex and Sephacryl column chromatography columns to obtain a polysaccharide with a relative molecular weight of 722.90 kDa with a molar ratio of 1:2.5.
The polysaccharide BSPS, which is efficiently extracted and purified wound healing from white and fresh tubers, significantly enhances the proliferation, differentiation and migration of C2C12 cells, promotes wound healing, and provides an effective pharmaceutical composition for wound treatment.
Smart Images

Figure CN118930673A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to uniform polysaccharides with wound healing effect, namely, bletilla striata polysaccharide BSPS, and a mixture containing the uniform polysaccharide, namely, bletilla total polysaccharide BSPt, which are extracted, separated and purified from fresh tubers of bletilla striata (Thunb.) Reichb.f., as well as preparation methods and pharmaceutical compositions with the polysaccharide as active ingredients, and their use in treating wounds. Background Art
[0002] The Chinese herbal medicine Bletilla striata is the dried tuber of the orchid Bletilla striata (Thunb.) Reichb.f. It has the functions of astringency, hemostasis, swelling and tissue regeneration. It is used for hemoptysis, hematemesis, bleeding from trauma, swelling and infection of sores and ulcers, and skin chapped skin. Modern pharmacological studies have confirmed that it has hemostatic, wound healing, anti-cancer, antiviral, anti-inflammatory, anti-fibrotic and immunomodulatory effects [XRHe, XXWang, JCFang, ZFZhao, LHHuang, H.Guo, XHZheng, Bletilla striata: medicinal uses, phytochemistry and pharmacological activities, J.Ethnopharmacol.195(2017)20–38; S.Jiang, MYWang, L.Jiang, Q.Xie, HWYuan, YPYang, S.Zafar, Y.Liu, YQJian, B.Li, W.Wang, 2021.The medicinal uses of the genus Bletilla in traditionalChinese medicine:A phytochemical and pharmacologicalreview.J.Ethnopharmacol.280,114263]. Bletilla striata mainly contains polysaccharides, phenanthrene, anthraquinone and saponin [C. Yang, T. Xia, C. Q. Wang, HY Sun, Y. J. Li, Z. P. Gong, Y. T. Li, L. Zheng, Y. Huang, 2019. Using the UPLC-ESI-Q-TOF-MS Emethod and intestinal bacteria for metaboliteidentification in the nonpolysaccharide fraction from Bletilla striata.Biomed.Chromatogr.33,e4637; Res.Int.2020,5391379]. Among them, polysaccharides are its main active ingredients, which have hemostatic, wound healing, gastroprotective, anti-tumor and immunomodulatory effects [C.Liu, KYDai, HYJi, XYJia, AJLiu, Structural characterization of a low molecular weight Bletillastriata polysaccharide and antitumor activity on H22 tumor-bearing mice. Int. J.Biol.Macromol.205(2022)553–56] and are widely used in the pharmaceutical, food and cosmetics industries [DLXu, YCPan, JSChen, 2019. Chemical constituents, pharmacologic properties, and clinical applications of Bletilla striata. Front. Pharmacol.10,1168].In recent years, Bletilla striata polysaccharide has been widely studied as a carrier material for drug delivery systems due to its non-toxicity, high safety, biocompatibility and biodegradability [WC Zhao, Q. Zhang, Y. Wang, JH Hou, Preparation, characterization and in vitro antitumor effect of cholesterol succinyl Bletilla striata polysaccharide-loaded paclitaxel nanoparticles, Biomed. Res. 28 (2017) 9638–9646; LL Hu, ZC Liao, QQ Hu, KG Maffucci, Y. Qu, Novel Bletilla striata polysaccharide microneedles: fabrication, characterization, and in vitro transcutaneous drug delivery.Int.J.Biol.Macromol.117(2018)928–936; Q.Zhang,C.Qi,H.Wang,XFXiao,Y.Zhuang,SJGu,YHZhou,L.Wang,HJYang,WLXu,2019.Biocompatible and degradable Bletilla striata polysaccharide hemostasissponges constructed from natural medicinal herb Bletillastriata.Carbohydr.Polym.226,115304].
[0003] So far, all the reported polysaccharides of Bletilla striata are isolated from the dried tubers of Bletilla striata. Compared with the dried medicinal materials, the active ingredients of fresh materials are more intact. In addition, all the Bletilla striata polysaccharides used to evaluate wound healing are crude polysaccharides.
[0004] The present invention adopts modern column chromatography technology to separate and purify a uniform polysaccharide, namely, Bletilla striata polysaccharide BSPS, from fresh tubers of Bletilla striata, and uses a variety of spectral and wave spectrum technologies combined with chemical analysis methods to characterize its structure; an in vitro mouse myoblast C2C12 cell model and an in vivo mouse skin injury experiment confirm that Bletilla striata polysaccharide BSPS has a wound healing effect. Summary of the invention
[0005] The primary purpose of the present invention is to provide a type of polysaccharide with wound healing effect.
[0006] The second object of the present invention is to provide a method for extracting and separating polysaccharides from fresh tubers of Bletilla striata (Thunb.) Reichb.f.
[0007] The third object of the present invention is to provide a method for analyzing the structure of Bletilla striata polysaccharide BSPS.
[0008] A further object of the present invention is to provide a pharmaceutical composition for treating wounds.
[0009] Another object of the present invention is to provide use of the polysaccharide and composition in treating wounds.
[0010] The polysaccharide with wound healing effect of the present invention comprises a pure polysaccharide, Bletilla striata polysaccharide BSPS, extracted, separated and purified from the fresh tuber of Bletilla striata (Thunb.) Reichb.f. and a mixture containing the homogeneous polysaccharide, Bletilla striata total polysaccharide BSPt. The relative molecular weight of Bletilla striata polysaccharide BSPS is 722.90 kDa, and it is composed of glucose and mannose in a molar ratio of 1:2.5.
[0011] The Bletilla striata polysaccharide BSPS and the mixture containing the uniform polysaccharide, namely, the Bletilla striata total polysaccharide BSPt provided by the present invention are extracted from the fresh tuber of the orchid Bletilla striata (Thunb.) Reichb.f., and the preparation method comprises the following steps:
[0012] a. Homogenize fresh tubers of Bletilla striata and extract with water.
[0013] b. Concentrate the water extract, add 95% ethanol to precipitate twice. Collect the precipitate and dissolve it in distilled water, deproteinize it with Sevage reagent (chloroform: n-butanol = 4:1), dialyze, concentrate the retentate under reduced pressure, and freeze-dry to obtain Bletilla striata total polysaccharide BSPt.
[0014] c. The total polysaccharide BSPt from Bletilla striata was separated by gel chromatography column and eluted with sodium chloride solution. Different eluates were collected, concentrated, desalted and freeze-dried to obtain two fractions.
[0015] d. The first fraction was purified by gel chromatography, eluted with sodium chloride solution, concentrated, desalted, and freeze-dried to obtain Bletilla striata polysaccharide BSPS.
[0016] The column chromatography gel described in the above step c is DEAE-Sephadex A-25, DEAE-Sephadex A-50, DEAE-Sepharose CL-4B, DEAE-Sepharose CL-6B, DEAE-Cellulose 32 or DEAE-Cellulose 52. The column chromatography gel described in step d is Sephadex G-100, Sephadex G-150, Sephadex G-200, Sephacryl S-300, Sephacryl S-400, Sepharose CL-4B or Sepharose CL-6B. The concentration of the sodium chloride solution in steps c and d is 0 to 2.0 mol / L.
[0017] The pharmaceutical composition of the present invention contains a therapeutically effective amount of Bletilla striata polysaccharide BSPS or Bletilla striata total polysaccharide BSPt as an active ingredient, and contains one or more pharmaceutically acceptable carriers.
[0018] The effective amount of the Bletilla striata polysaccharide BSPS or the Bletilla striata total polysaccharide BSPt of the present invention is 0.01 μg / kg to 100 mg / kg body weight.
[0019] The polysaccharide and pharmaceutical composition of the present invention can be used to treat wounds.
[0020] The pharmaceutically acceptable carriers mentioned above refer to drug carriers in the pharmaceutical field. For example: diluents, excipients such as water, saline, glucose, mannitol, glycerol, ethanol or a mixture thereof; fillers such as starch, sucrose, etc.; binders such as cellulose derivatives, alginate, gelatin, polyvinyl pyrrolidone or a mixture thereof; wetting agents such as glycerol; disintegrants such as calcium carbonate and / or sodium bicarbonate; absorption promoters such as quaternary ammonium compounds; surfactants such as Tween-80; lubricants such as talc, calcium stearate, magnesium stearate, polyethylene glycol or a mixture thereof.
[0021] The compounds of the present invention can be administered to patients who need such treatment or subjects who need vaccination in the form of compositions by oral, nasal inhalation, rectal, parenteral or transdermal administration. When used for oral administration, it can be made into conventional solid preparations such as tablets, powders, granules, capsules, pills, sustained-release pellets, solid dispersions, inclusions, etc., and liquid preparations such as suspensions, emulsions, sols, syrups, mixtures, solutions, etc.; when used for parenteral administration, it can be made into solutions for injection, water or oily suspensions, emulsions, lyophilized powders, liposomes, microcapsules, microspheres, nanocapsules, nanospheres, etc. Preferred forms are tablets, coated tablets, capsules, pellets, suppositories and injections, and preparations for targeted release at specific sites are particularly preferred.
[0022] The various dosage forms of the pharmaceutical composition of the present invention can be prepared according to conventional production methods in the pharmaceutical field, for example, by mixing the active ingredient with one or more carriers and then preparing the mixture into the desired dosage form.
[0023] The pharmaceutical composition of the present invention preferably contains active ingredients in an amount of 0.01% to 99.9% by weight, and most preferably contains active ingredients in an amount of 0.5% to 95% by weight.
[0024] The polysaccharide of the present invention exhibits wound healing effects, can significantly enhance the proliferation, differentiation and migration of C2C12 cells, promotes wound epithelialization and the generation of new granulation tissue, accelerates wound healing in mice, and can be used as a medicine for treating trauma. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Figure 1 The separation and purification, molecular weight, monosaccharide composition and physicochemical properties of BSPS in fresh tubers of Bletilla striata. A is the elution curve of total polysaccharide BSPt of Bletilla striata on Sephadex G200 column. B is the elution curve of fraction 1 (F1) on DEAE Sephadex A50 column. C is the HPGPC chromatogram of Bletilla striata polysaccharide BSPS, and the peak at 47.606min is the peak of mobile phase NaCl. D is the HPLC chromatogram of monosaccharide standard PMP derivative; E is the HPLC chromatogram of BSPS monosaccharide PMP derivative. 1: D-mannose (Man); 2: D-glucosamine hydrochloride (GlcN); 3: L-rhamnose (Rha); 4: D-glucuronic acid (Glc-UA); 5: D-galacturonic acid (Gal-UA); 6: D-galactosamine hydrochloride (GalN); 7: D-glucose (Glc); 8: D-galactose (Gal); 9: D-xylose (Xyl); 10: L-arabinose (Ara); 11: L-fucose (Fuc). F is the GC-MS spectrum of the methylation product of Bletilla striata polysaccharide BSPS. G is the infrared spectrum of Bletilla striata polysaccharide BSPS.
[0026] Figure 2 is the NMR spectrum of Bletilla striata polysaccharide BSPS. 1 H NMR (A), 13 CNMR(B), 1 H- 1 HCOSY(C), HSQC(D), HMBC(E) and NOESY(F); G is the repeating structural unit of Bletilla striata polysaccharide BSPS (n≈600).
[0027] Figure 3The conformation and ultrastructure of Bletilla striata polysaccharide BSPS. A is the result of Congo red experiment; B is the scanning electron microscope image of Bletilla striata polysaccharide; C and D are the AFM plane image (C) and three-dimensional image (D) of Bletilla striata polysaccharide.
[0028] Figure 4 The effect of BSPS on the proliferation and differentiation of C2C12 cells. A is the MTT assay to detect the viability of C2C12 cells; B is the RT-qPCR assay to detect the expression level of MyHC gene. b P < 0.01 and c P<0.001vs 0μg / mL. C is the expression level of MYH (B-5) protein detected by IFA.
[0029] Figure 5 is the effect of BSPS on C2C12 cell migration. c P<0.001vs 0μg / mL.
[0030] Figure 6 The effect of BSPS on C2C12 cell invasion. a P<0.05and b P<0.01vs 0μg / mL.
[0031] Figure 7 The effect of BSPS on wound healing in mice. A is the wound healing rate in mice. B is a photo of wound contraction in mice. C is the pathological changes in mouse skin tissue. DETAILED DESCRIPTION
[0032] The present invention is further illustrated by the following examples without limiting the scope thereof.
[0033] Example 1: Preparation of Bletilla striata polysaccharide
[0034] 1. Preparation of total polysaccharides from Bletilla striata
[0035] 500g of fresh tubers of Bletilla striata were homogenized, and 12 times of water was added to heat and reflux for 2h, filtered, and the residue was further extracted with water for reflux. The filtrate was combined, recovered under reduced pressure to 500mL, and 8 times of volume of 95% ethanol was added, mixed, and allowed to stand at 4℃ for 24 hours, and filtered under reduced pressure with filter paper. The precipitate was dissolved in distilled water, and 8 times of volume of 95% ethanol was added, and the treatment was repeated once. The precipitate was dissolved in distilled water, and Sevage reagent (chloroform:: n-butanol = 4:1) was added in a ratio of 4:1, shaken vigorously, centrifuged at 3500rpm for 10min, and the protein and the lower organic solvent were discarded. The upper liquid was repeated with the above operation until the UV scan showed no protein. The decompression concentration was lyophilized to obtain the total polysaccharide BSPt of Bletilla striata, and the yield was 9.24%. The total polysaccharide of Bletilla striata is composed of glucose and mannose.
[0036] 2. Preparation of Bletilla striata Polysaccharide BSPS
[0037] The total polysaccharide of Bletilla striata was separated by Sephadex G-200 column, eluted with 0.1 mol / L sodium chloride, and the eluate with 0.1 mol / L sodium chloride was collected, concentrated, dialyzed (7000 Da), and freeze-dried to obtain fractions F1 (81.87%) and F2 (small amount) (attached Figure 1 Fraction F1 was purified by DEAE Sephadex A50 column, eluted with 0-2.0 mol / L sodium chloride, concentrated, desalted, and freeze-dried to obtain Bletilla striata polysaccharide BSPS (49.23%) (Attached Figure 1 Middle B). The total sugar and acetyl contents of Bletilla striata polysaccharide BSPS were (98.09±0.29)% and (4.71±0.02)%, respectively, without sulfonic acid group and uronic acid.
[0038] Example 2: Molecular weight of Bletilla striata polysaccharide BSPS
[0039] Weigh BSPS (5 mg) of Bletilla striata polysaccharide, dissolve it in ultrapure water, make a solution with a concentration of 1 mg / mL, and filter it with a 0.45 μm filter membrane to obtain the sample solution. Separately, standard Dextran with different molecular weights (1000, 5000, 12000, 25000, 50000, 150000, 270000, 410000 and 670000) was used to prepare a series of standard solutions. Waters 1515 liquid chromatography system, Shodex ks805 column (8.0×300 mm), Shodex tandem columns (OHpak SB-803HQ, Ohpak SB-804HQ and Ohpak SB-805HQ), Waters 2410 differential detector, 0.5 mol / L sodium chloride as mobile phase, flow rate 0.65 mL / min, column temperature 40°C, injection volume 30 μL were used for determination. The molecular weight of Bletilla striata polysaccharide BSPS is 722.90 kDa ( Figure 1 Middle C).
[0040] Example 3: Monosaccharide composition and molar ratio of Bletilla striata polysaccharide BSPS
[0041] Sample preparation: Weigh 5 mg of Bletilla striata polysaccharide sample, add 1 mL of 2 mol / L TFA acid solution, and heat at 121°C for 2 hours. Pass nitrogen and blow dry. Add 3 mL of methanol to wash, blow dry again, and repeat the methanol washing 3 times. Add 5 mL of sterile water to dissolve, transfer to a chromatographic bottle for testing. Take 0.2 mL of monosaccharide standard solution or polysaccharide hydrolyzate in a stoppered conical bottom centrifuge tube, add 0.2 mL of 0.5 mol / L sodium hydroxide solution, 0.5 mL of 0.5 mol / L PMP methanol solution, vortex to mix, and react in a 70°C water bath for 1 hour. After completion, add 0.2 mL of 0.5 mol / L hydrochloric acid to neutralize the remaining sodium hydroxide, add 1 mL of chloroform, vortex extract 3 times, and remove excess PMP. After discarding the chloroform layer, take 0.3 mL and add water to make it up to 1 mL.
[0042] Detection: Thermo U3000 liquid chromatography system, the chromatographic column is ZORBAX EclipseXDB-C18, the mobile phase is acetonitrile: phosphate buffer (12 g / L potassium dihydrogen phosphate, 2 mol / L NaOH to adjust the pH to 6.8) isocratic elution, the volume ratio of acetonitrile to phosphate buffer is 17:83, the flow rate is 0.8 mL / min, the column temperature is 30°C, the detection wavelength is 250 nm, and the injection volume is 10 μL.
[0043] The results showed that Bletilla striata polysaccharide BSPS was composed of glucose and mannose in a molar ratio of 30.25:69.75 (ca.1:2.5) (Appendix Figure 1 D and attached Figure 1 Middle E).
[0044] Example 4: Methylation analysis of Bletilla striata polysaccharide BSPS
[0045] Sample derivatization: Weigh 10 mg of Bletilla striata polysaccharide BSPS sample, add 1 mL of first-grade water to dissolve, and add 1 mL 100 mg / mL carbodiimide, react for 2 h; add 1 mL 2 mol / L imidazole, add 1 mL 30 mg / mL NaBD 4 , react for 3 hours; add 100 μL glacial acetic acid to terminate the reaction. Dialyze the sample for 48 hours, freeze-dry, and perform methylation treatment; Add 500μL DMSO to the freeze-dried sample to dissolve; accurately weigh 1mg of the sample to be tested, add 500μL DMSO to dissolve; add 1mg NaOH and incubate for 30min; add 50μL iodomethane solution and react for 1h; add 1mL water and 2mL dichloromethane, vortex to mix, centrifuge, discard the water phase, and repeat the water washing 3 times; absorb the lower dichloromethane phase and evaporate to dryness, add 100μL 2mol / L TFA, and react at 121℃ for 90min. Evaporate to dryness at 30℃, add 50μL 2mol / L ammonia water, 50μL 1mol / L NaBD4 , mix well, react at room temperature for 2.5h; add 20μL acetic acid to terminate the reaction, blow dry with nitrogen, Wash twice with 250 μL methanol and blow dry with nitrogen; add 250 μL acetic anhydride, vortex mix, react at 100°C for 2.5 h; add 1 mL water and let stand for 10 min; add 500 μL dichloromethane, vortex mix, centrifuge, discard the aqueous phase, and repeat washing with water 3 times; Take the lower dichloromethane phase and test it on the instrument.
[0042] Detection: Agilent 7890A-5977B gas chromatography-mass spectrometer was used for detection. The chromatographic system used an Agilent 7890A gas chromatography system (Agilent Technologies, USA), an HP-5MS capillary column (30m×0.25mm×0.25μm, Agilent J&W Scientific, Folsom, CA, USA), a carrier gas of high-purity helium (purity not less than 99.999%), a flow rate of 1.0mL / min, and an injection port temperature of 260°C. The injection volume was 1μL, split injection, split ratio 10:1, and solvent delay 2.2min. Program temperature rise: 50°C for 1.0min, 50°C / min to 130°C, 3°C / min to 230°C, and held for 2min. The mass spectrometry system used was an Agilent 5977B quadrupole mass spectrometry detection system (Agilent Technologies, USA), equipped with an electron impact ion source (EI) and a MassHunter workstation. The electron impact ion source (EI), the injection port temperature was 230°C, the quadrupole temperature was 150°C, and the electron energy was 70 eV. The scanning mode was full scan mode (SCAN), and the mass scanning range (m / z): 30-600.
[0043] The results of methylation analysis of Bletilla striata polysaccharide BSPS are shown in the attached Figure 1 F. Bletilla striata polysaccharide BSPS contains two kinds of sugar residues: →4)-D-Man p -(1→ and →4)-D-Glc p -(1→. The molar ratio of mannose to glucose was 2.5:1 (Table 1).
[0044] Table 1 Results of methylation analysis of Bletilla striata polysaccharide BSPS
[0045] Example 5: Infrared spectroscopy (IR) analysis of Bletilla striata polysaccharide BSPS
[0046] Thermo Nicolet 5700 FT-IR Fourier transform infrared spectrometer was used, KBr pellets were pressed at room temperature, and the frequency range was 4000-400 cm -1Scanning within the range with a resolution of 4cm -1 . At 3405cm -1 There is a broad absorption peak at 2889cm -1 The weak absorption band is the C–H stretching vibration of the sugar ring; 1735 cm -1 and 1614cm -1 The absorption peak indicates the presence of ester carbonyl; 1379cm -1 It is the absorption peak of methyl symmetric bending vibration; 1251cm -1 and 1062cm -1 The stretching vibration absorption peaks of C–O–C and C–O–H are shown in Figure 2. Figure 1 Middle G).
[0047] Example 6: Nuclear Magnetic Resonance (NMR) Analysis of Bletilla striata Polysaccharide BSPS
[0048] Weigh 10 mg of Bletilla striata polysaccharide BSPS sample and dissolve it in 0.5 mL D 2 O, TMS was added as internal standard. One-dimensional NMR was measured using AVANCE HD III 600 MHz NMR spectrometer from Bruker, Germany. 1 H-NMR, 13 C-NMR, DEPT-135 and 2D NMR 1 H- 1 H COSY, HSQC, HMBC, NOESY.
[0049] like Figure 2 As shown, the Bletilla striata polysaccharide BSPS 1 H and 13 In the C-NMR spectrum, most of the signals are concentrated in a relatively narrow δ H 3.0~5.1ppm and δ C 50~110ppm, which is a typical polysaccharide characteristic. Anomeric hydrogen chemical shift δ H 4.41, 4.65 and 5.08 ppm and anomeric carbon δ C 104.88 and 102.51 ppm indicated that the polysaccharide BSPS of Bletilla striata contained three different types of monosaccharide residues. 1 H and 13 The chemical shifts of C are shown in Table 1. The repeating structural unit of Bletilla striata polysaccharide BSPS is →4)-β-D-Glc p -(1→4)-β-D-Man p -(1→4)-β-D-Man p -(1→4)-β-D-Glc p -(1→4)-β-D-Man p-(1→4)-β-D-Man p -(1→4)-β-D-Man p -(1→.
[0050] Table 2 Bletilla striata polysaccharide BSPS 1 H and 13 C chemical shift (δ, ppm)
[0051] Example 6: Congo red test of Bletilla striata polysaccharide BSPS
[0052] Weigh BSPS, a polysaccharide of Bletilla striata, and dissolve it in double distilled water to make a 2 mg / mL solution; take 1 mL of the polysaccharide solution and 3 mL of NaOH solutions of different concentrations, mix well, then add 1.5 mL of 0.2 mmol / L Congo red solution and 0.5 mL of double distilled water, mix well, and let stand for 1 hour. Use a mixture of Congo red solution and a sodium hydroxide solution of corresponding concentration as a control, and use a Tu-1901 ultraviolet spectrophotometer to detect the maximum absorption wavelength. Figure 3 As shown in A, the maximum absorption wavelength of the Bletilla striata polysaccharide BSPS-Congo red complex is significantly greater than that of Congo red alone at the same sodium hydroxide solution concentration, suggesting that the Bletilla striata polysaccharide BSPS solution has a triple helical structure.
[0053] Example 7: Microstructure Observation of Bletilla striata Polysaccharide BSPS
[0054] The powder of Bletilla striata polysaccharide was placed on a sample holder fixed with double-sided tape, and the surface was treated with gold spraying. The microstructure of the sample was observed under high vacuum conditions using a field emission scanning electron microscope (SEM) at an accelerating potential of 3.0 kV. A 10 μg / mL Bletilla striata polysaccharide BSPS solution was prepared with double distilled water, and the polysaccharide solution was evenly coated on a mica sheet (1.0×1.0 cm 2 ) and dried naturally. The structure was observed using an atomic force microscope (AFM). Under SEM and AFM, it was observed that BSPS had chain and scale structures (attached Figure 3 Due to the interaction between free OH groups, several chains aggregate and curl to form a spherical structure with a length of about 1.8 μm and a diameter of about 20 nm (see Figure 2). Figure 3 C and attached Figure 3 These observations further support the existence of a triple helical structure in BSPs.
[0055] Example 8: Effect of Bletilla striata polysaccharide BSPS on C2C12 cell proliferation
[0056] Methods: C2C12 cells were cultured at 1×10 5 / mL concentration was plated in a 96-well plate, 100 μL / well, and placed at 37°C, 5% CO 2In a cell culture incubator. After 24 hours of adherent culture, the culture medium was discarded, and DMEM culture medium or 2% horse serum complete culture medium with different concentrations of Bletilla striata polysaccharide BSPS (final concentrations of 0, 3.125, 6.25, 12.5, 25, 50, 100, 200 and 400 μg / mL) was added, and culture was continued for 48 hours. The absorbance was detected at 492 nm using an enzyme marker using the MTT method.
[0057] Results: As attached Figure 4 As shown in A, BSPS promoted the proliferation of C2C12 cells in the concentration range of 3.125-12.5 μg / mL, had no significant effect on the proliferation of C2C12 cells at 25-100 μg / mL, and significantly inhibited the proliferation of C2C12 cells at 200 and 400 μg / mL (P<0.001). BSPS concentrations of 3.125-25 μg / mL significantly promoted the proliferation of C2C12 cells treated with 2% horse serum (P<0.01 or P<0.001), while 50-400 μg / mL had no significant effect (P>0.05). These results indicate that Bletilla striata polysaccharide BSPS can promote the proliferation of C2C12 and its differentiated cells.
[0058] Example 9: Effect of Bletilla striata polysaccharide BSPS on C2C12 cell differentiation
[0059] RT-qPCR was used to detect the effect of BSPS on the expression of differentiation genes in C2C12 cells. 4 / mL), and inoculated into 24-well plates at 1mL / well. 2 Cell culture incubator. After 24 hours of adherent culture, the culture medium was discarded, and DMEM culture medium or 2% horse serum complete culture medium with different concentrations of Bletilla striata polysaccharide BSPS (final concentration 0, 25, 50, 100 μg / mL) was added, and culture was continued for 24 hours. Cell samples were collected, total RNA was extracted using TRIzol reagent, and RT-qPCR was used to detect the expression level of myosin heavy chain MyHC gene.
[0060] IFA was used to analyze the expression level of MYH (B-5) protein in C2C12 cells. 4 / mL), and inoculated into 24-well plates at 1mL / well. 2Cultured in a cell culture incubator. After 24 hours of attachment, add DMEM culture medium with different concentrations of BSPS solution (final concentrations of 0, 25, 50, and 100 μg / mL) for 72 hours. Collect the samples, pour off the culture medium, and wash three times with PBS. Add 4% universal tissue fixative to each well for 15 minutes, and wash three times with PBS; add 0.5% Triton X-100 (diluted with PBS buffer) to each well for permeabilization for 20 minutes, and wash three times with PBS; add blocking solution (PBS buffer containing 5% BSA) to each well, block for 30 minutes at room temperature, and wash three times with PBS. Add 300 μL MYH (B-5) primary antibody (1:500) to each well, incubate overnight in a 4℃ wet box, rewarm at 37℃ for 1 hour, and wash three times with PBS. Add 300 μL goat anti-mouse IgG secondary antibody (1:1000, diluted with blocking solution) to each well, incubate for 2 hours at room temperature in the dark, and wash three times with PBS. 200 μL DAPI (1:1000) was added to each well, incubated at room temperature in the dark for 5 min, washed 3 times with PBS, observed under a fluorescence microscope, and photographed.
[0061] As attached Figure 4 As shown in Figure B, BSPS, a polysaccharide from Bletilla striata, could up-regulate the expression level of MyHC gene in C2C12 cells and myotube cells in a concentration-dependent manner (P<0.05, P<0.01 or P<0.001). Figure 4 As shown in C, with the increase of the concentration of Bletilla striata polysaccharide BSPS, the number of green fluorescent cells increased, indicating that Bletilla striata polysaccharide BSPS can upregulate the expression level of MYH (B-5) protein in C2C12 cells. These results show that BSPS can induce and promote the differentiation of C2C12 cells.
[0062] Example 10: Effect of Bletilla striata polysaccharide BSPS on the migration ability of C2C12 cells
[0063] C2C12 cells (4×10 4 / mL), and inoculated into 24-well plates at 1mL / well. 2 Culture in a cell culture incubator. After 48 hours, use a 1mL pipette tip to slowly and evenly scratch along the vertical line; after the line is drawn, the culture medium is aspirated and the DMEM culture medium containing different concentrations of Bletilla striata polysaccharide BSPS is added (the final concentrations are 0, 25, 50, and 100 μg / mL). At 0 hours, 24 hours, 48 hours, and 72 hours, the 24-well plate is placed under an inverted microscope for observation and photography, and the width of the cell scratch is measured using Oplenic software, and the cell migration rate is calculated. Cell migration rate = (initial width of the cell scratch – width of the cell scratch at a specific time) / initial width of the cell scratch × 100%.
[0064] As attached Figure 5The results showed that Bletilla striata polysaccharide BSPS could increase the migration rate of C2C12 cells in a concentration- and time-dependent manner (P<0.05, P<0.01 or P<0.001), indicating that BSPS could promote the migration ability of C2C12 cells.
[0065] Example 11: Effect of Bletilla striata polysaccharide BSPS on the invasion ability of C2C12 cells
[0066] Corning 24-well Transwell chamber was used for cell invasion experiment. Matrix gel was diluted with DMEM medium (1:6), added to the upper chamber of the chamber at 100 μL / well, and incubated at 37°C overnight to solidify the matrix gel. C2C12 cells were mixed with different concentrations of Bletilla striata polysaccharide BSPS (final concentrations were 0, 25, 50, and 100 μg / mL) and 5×10 4 100 μg / well were inoculated in the upper chamber of the chamber, and 0.7 mL of DMEM culture medium containing 10% FBS was added to the lower chamber of the chamber and placed at 37°C and 5% CO. 2 Incubate in an incubator for 24 hours. Fix cells with 4% paraformaldehyde for 30 minutes and stain with 0.1% crystal violet stain for 10 minutes at room temperature. Use cotton swabs to remove non-invasive cells, and observe and photograph with an Olympus CKX31 inverted microscope. 5 random fields of view are counted for each sample. ImageJ software is used to analyze images. The invasion rate is expressed as the multiple of the number of migrated cells compared with the control group.
[0067] As attached Figure 6 As shown, the average migration rates of C2C12 cells treated with BSPS at concentrations of 25, 50, and 100 mg / mL were 1.84, 2.40, and 4.65 times that of the control cells, respectively. It can be seen that BSPS enhanced the invasiveness of C2C12 cells in a concentration-dependent manner.
[0068] Example 12: Effect of Bletilla striata polysaccharide BSPS on wound healing in mice
[0069] Preparation of Bletilla striata polysaccharide BSPS / Vaseline paste: Weigh 500 mg of polysaccharide sample and dissolve it in 10 mL of double distilled water to prepare 50 mg / mL Bletilla striata polysaccharide BSPS solution; take another 10 mL of double distilled water and sterilize it with circulating steam for 30 minutes. Weigh 2 portions of vaseline (50 g) respectively and place them in an oven for dry heat sterilization at 180°C for 2 hours. Mix the Bletilla striata polysaccharide BSPS solution and double distilled water with vaseline respectively and stir for 30 minutes to mix them completely. After cooling, they solidify to form a thinner paste. The negative control group drug and the test drug are obtained and stored in a 4°C refrigerator for standby use.
[0070] Modeling: 75 mice were randomly divided into 5 groups, negative control group, positive control group, low-dose, medium-dose and high-dose groups of Bletilla striata polysaccharide BSPS, 15 mice in each group, and each group was fed in 3 cages. Anesthesia was performed by intraperitoneal injection of 0.375% sodium pentobarbital aqueous solution at a volume of 0.20 mL per 10 g body weight. After the mice entered the anesthetized state, the hair on the back of the mice was first wetted with clean water, and then the depilatory cream was applied to the back of the mice. The depilatory cream was evenly spread on the back with a scraper. After 10 minutes, clean water was added, and the hair on the back was gently scraped off with a scraper. The back skin was cleaned with a cotton ball dipped in clean water to prevent the depilatory cream from remaining for too long and causing damage to the mouse skin. The back skin was wiped dry with a paper towel. Then one hand pinched the back skin, and the other hand used a puncher to make a wound, forming two symmetrical full-thickness circular wounds with a diameter of 10 mm on the back of the mouse.
[0071] Administration: Weigh double distilled water / vaseline paste (0.1 g, negative control), BSPS / vaseline paste (0.05 g, 0.1 g and 0.2 g) and recombinant bovine basic fibroblast growth factor gel (0.1 g, positive control), divide them into 2 portions, and apply them evenly on the surface and edges of the two wounds on the back of the mouse with a small medicine spoon. Change the dressing once a day at a fixed time for 12 consecutive days.
[0072] Observation of wound healing in mice: Two days after administration, the diameter of the mouse wound was photographed and measured every day using a "ruler measuring distance meter" to calculate the wound healing rate
[137] Wound healing rate (%) = (initial wound size - wound size on the day of measurement) / initial wound size × 100%.
[0073] Wound histopathological observation: On the 4th and 8th day of administration and 24 h after the last administration, 5 mice in each group were killed, and the wound tissues were fixed in 4% neutral buffered formalin solution, embedded in paraffin, cut into 4 μm thick sections, stained with hematoxylin and eosin (H&E), and observed and photographed using an Olympus CKX31 inverted microscope.
[0074] Bletilla striata polysaccharide BSPS can significantly reduce the wound area of mice in a dose- and time-dependent manner (attached Figure 7 BSPS also accelerated hair production in the skin, especially at high doses, which was comparable to the healing efficiency of rb-bFGF (Supplementary Figure 7 Histopathological examination showed that BSPS not only reduced inflammatory cell infiltration and epidermal and subcutaneous necrosis in a dose- and time-dependent manner, but also accelerated the formation of granulation tissue in wounded skin (see Appendix Figure 7 These results indicate that BSPS can reduce inflammatory cell infiltration, promote epidermal regeneration, and promote wound healing.
Claims
1. A polysaccharide having a wound healing effect, characterized in that It is a pure polysaccharide extracted, separated and purified from the fresh tuber of Bletilla striata (Thunb.) Reichb.f., namely Bletilla striata polysaccharide BSPS, and a mixture containing this uniform polysaccharide, namely Bletilla striata total polysaccharide BSPt; the relative molecular weight of the Bletilla striata polysaccharide BSPS is 722.90 kDa, and it is composed of glucose and mannose in a molar ratio of 1:2.
5.
2. The polysaccharide having wound healing effect according to claim 1, characterized in that There is an O-acetyl group in its linear straight chain structure.
3. The method for preparing the polysaccharide having wound healing effect according to claim 1, wherein the specific steps are as follows: a. Homogenize the fresh tubers of Bletilla striata and extract with water; b. Concentrate the water extract, precipitate twice with 95% ethanol, collect the precipitate, dissolve it in distilled water, deproteinize it with Sevage reagent, dialyze it, concentrate the retentate under reduced pressure, and freeze-dry it to obtain total polysaccharide BSPt of Bletilla striata; c. Bletilla striata total polysaccharide BSPt was separated by gel chromatography column, eluted with sodium chloride, and different eluates were collected, concentrated, desalted, and freeze-dried to obtain 2 fractions; d. The first fraction was purified by gel chromatography, eluted with sodium chloride solution, concentrated, desalted, and freeze-dried to obtain Bletilla striata polysaccharide BSPS.
4. The preparation method according to claim 3, characterized in that the gel chromatography column in step c is DEAE-Sephadex A-25, DEAE-Sephadex A-50, DEAE-Sepharose CL-4B, DEAE-Sepharose CL-6B, DEAE-Cellulose 32 or DEAE-Cellulose 52.
5. The preparation method according to claim 3, characterized in that the gel chromatography column in step d is Sephadex G-100, Sephadex G-150, Sephadex G-200, Sephacryl S-300, Sephacryl S-400, Sepharose CL-4B or Sepharose CL-6B.
6. A pharmaceutical composition for treating trauma, comprising a therapeutically effective amount of the Bletilla striata polysaccharide BSPS or the Bletilla striata total polysaccharide BSPt as claimed in claim 1 and a pharmaceutically acceptable carrier.
7. The pharmaceutical composition according to claim 6, characterized in that The effective amount of Bletilla striata polysaccharide BSPS or Bletilla striata total polysaccharide BSPt is 0.01 μg / kg to 100 mg / kg body weight.
8. Use of the polysaccharide according to claim 1 in treating wounds.
Citation Information
Patent Citations
Multifunctional bletilla striata medical material, and preparation method and application thereof
CN112675354A
Cited By
Biological product for regulating and controlling blood sugar of type I diabetes mellitus
CN120617297A
